New Study Highlights Importance of Measuring Activated Proteins in Cancer Therapy Selection In a groundbreaking development, Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., has announced the publication of a significant study in the prestigious British Journal of Cancer. The study, titled “Functional activation of the AKT–mTOR signalling axis in a real-world metastatic breast…

Jyoti Bansal’s Latest Venture: Merging Harness and Traceable Jyoti Bansal, the brilliant mind behind AppDynamics, which was sold to Cisco for a whopping $3.7 billion, is at it again. This time, he’s leading two startups, Harness and Traceable, and merging them into one powerhouse company. About Harness and Traceable Harness, founded in 2016, offers continuous…

The Revitalized Momentum of Qualcomm Inc. (QCOM): A New Hope for Shareholders For months, the stock market has witnessed a stagnant trend for tech giant Qualcomm Inc. (QCOM). However, recent developments have brought renewed optimism to investors, as the shares have experienced a 10% surge since December 2022. Let’s delve deeper into the factors fueling…

Exploring the Future of Cloudflare (NET) Cloudflare, Inc. (NET), a leading internet performance and security company, has recently garnered significant attention from investors and analysts. Zacks.com, a popular investment research platform, has reported an increase in user interest towards this stock. Let’s delve deeper into the factors driving this trend and what it could imply…

Telus International (TIXT) Investors: Understanding Your Potential Recovery Options under Federal Securities Laws If you’ve recently experienced financial losses due to your investment in TELUS International (TIXT), you’re not alone. The technology sector has seen its fair share of volatility in recent times, and it’s natural to feel concerned about the future of your investment….

Exploring Realty Income Corp. (O): A Closer Look for Zacks.com Users Lately, Realty Income Corp. (O) has been generating significant interest among Zacks.com users. This Real Estate Investment Trust (REIT) is renowned for its monthly dividends, making it an attractive option for income-focused investors. Let’s delve deeper into what sets Realty Income apart and discuss…

Important Information for Regeneron Pharmaceuticals Investors: Rosen Law Firm Announces Class Action Lawsuit and Lead Plaintiff Deadline On February 23, 2025, Rosen Law Firm, a global investor rights law firm, issued a press release reminding purchasers of securities of Regeneron Pharmaceuticals, Inc. (Regeneron) (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates…